Oxford Index Search Results

You are looking at 1-8 of 8 items for:

Zyvox x clear all

Refine by type

Refine by product

 

Zyvox

Overview page. Subjects: Chemistry.

another name for Linezolid.

See overview in Oxford Index

Zyvox

Overview page. Subjects: Chemistry.

another name for Linezolid.

See overview in Oxford Index

Zyvox

Edited by Richard Cammack, Teresa Atwood, Peter Campbell, Howard Parish, Anthony Smith, Frank Vella and John Stirling.

in Oxford Dictionary of Biochemistry and Molecular Biology

January 2006; p ublished online January 2008 .

Reference Entry. Subjects: Biochemistry. 5 words.

another name for Linezolid.

Go to Oxford Reference »  home page

Oxazolidinone susceptibility patterns in 2004: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations

Ronald N. Jones, James E. Ross, Thomas R. Fritsche and Helio S. Sader.

in Journal of Antimicrobial Chemotherapy

February 2006; p ublished online December 2005 .

Journal Article. Subjects: Medical Oncology; Critical Care. 5674 words.

Objectives: To investigate the activity of linezolid (an oxazolidinone), a potent choice for community- and hospital-acquired infections, via a worldwide surveillance network...

Go to Oxford Journals »  abstract

Zyvox<sup>®</sup> Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004–12)

Rodrigo E. Mendes, Patricia A. Hogan, Jennifer M. Streit, Ronald N. Jones and Robert K. Flamm.

in Journal of Antimicrobial Chemotherapy

June 2014; p ublished online January 2014 .

Journal Article. Subjects: Medical Oncology; Critical Care. 3739 words.

Objectives

To summarize the activity and spectrum of linezolid and comparators tested against 7972 Gram-positive clinical isolates as part of the Zyvox® Annu...

Go to Oxford Journals »  home page

Surveillance for linezolid resistance via the Zyvox<sup>®</sup> Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates

Rodrigo E. Mendes, Patricia A. Hogan, Ronald N. Jones, Helio S. Sader and Robert K. Flamm.

in Journal of Antimicrobial Chemotherapy

July 2016; p ublished online March 2016 .

Journal Article. Subjects: Medical Oncology; Critical Care. 4023 words.

Objectives

The objective of this study was to report the linezolid in vitro activity observed during the Zyvox® Annual Appraisal of Potency and Spectrum...

Go to Oxford Journals »  home page

Prospective, randomized study comparing quinupristin–dalfopristin with linezolid in the treatment of vancomycin-resistant <i>Enterococcus faecium</i> infections

Issam Raad, Ray Hachem, Hend Hanna, Claude Afif, Carmen Escalante, Hagop Kantarjian and Kenneth Rolston.

in Journal of Antimicrobial Chemotherapy

April 2004; p ublished online April 2004 .

Journal Article. Subjects: Medical Oncology; Critical Care. 2454 words.

Objectives: Quinupristin–dalfopristin and linezolid have been shown to be efficacious in the treatment of vancomycin-resistant Enterococcus faecium (VREF) infections. However,...

Go to Oxford Journals »  abstract

linezolid

Overview page. Subjects: Clinical Pharmacology and Therapeutics.

An antibiotic used against antibiotic-resistant Gram-positive streptococci. The first clinically available oxazolidinone, chemically unrelated to other antibiotics. Acts by blocking the...

See overview in Oxford Index

Cost avoidance using linezolid for methicillin-resistant <i>Staphylococcus aureus</i> infections in a specialist diabetes foot clinic

Matthew J. Young, Gemma Hodges and Joanne E. McCardle.

in Journal of Antimicrobial Chemotherapy

December 2012; p ublished online August 2012 .

Journal Article. Subjects: Medical Oncology; Critical Care. 1200 words.

Objectives

An audit was performed to determine whether linezolid (Zyvox, Pharmacia Limited, Sandwich, UK) was being used in accordance with local guidelines...

Go to Oxford Journals »  abstract